Skip to main content

GOLDMAN SACHS GROUP INC

Position in TNGX — Tango Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$311,994,180
+$205,796,061 QoQ
Shares Held
9,980,620
+96.6% QoQ
Ownership
5.92%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#6
of 247 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. TNGX ranks #7 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TNGX
Tango Therapeutics, Inc.
This page
9,980,620 $311,994,180

All Filings in TNGX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $304,547,486 9,742,402
2026-06-30 $311,994,180 9,980,620
2026-03-31 $106,198,119 5,076,392
2025-12-31 $43,789,787 4,942,414
2025-09-30 $12,679,590 1,509,475
2025-06-30 $553,875 108,179
2025-03-31 $236,232 172,433
2024-12-31 $1,504,483 486,888
2024-09-30 $4,184,926 543,497
2024-06-30 $5,275,996 614,918
2024-03-31 $4,872,793 613,702
2023-12-31 $4,447,228 449,215
2023-09-30 $1,293,323 114,860
2023-06-30 $300,682 90,567
2023-03-31 $320,577 81,159
2022-12-31 $507,746 70,034
2022-09-30 $994,000 274,586
2022-06-30 $364,189 80,395
2022-03-31 $771,537 101,786
2021-12-31 $903,709 82,606